VKTX

Viking Therapeutics, Inc. VKTX

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$0

Quarter to Jun 30

Net income

$-128.02M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$2.95B total
FMR LLC
$247.16M+5.2%
BlackRock, Inc.
$241.46M-10.0%
STATE STREET CORP
$218.71M+27.5%
VANGUARD CAPITAL MANAGEMENT LLC
$197.14M+0.8%
VANGUARD PORTFOLIO MANAGEMENT LLC
$174.93M+0.4%
TWO SIGMA INVESTMENTS, LP
$153.60M-11.2%
MORGAN STANLEY
$135.99M+15.7%
AMERIPRISE FINANCIAL INC
$84.11M+28.4%
GEODE CAPITAL MANAGEMENT, LLC
$81.87M+0.8%
AMERICAN CENTURY COMPANIES INC
$70.84M-12.6%
D. E. Shaw & Co., Inc.
$62.65M-4.2%
BNP PARIBAS FINANCIAL MARKETS
$38.30M+81.6%
CITADEL ADVISORS LLC
$37.12M-24.6%
GOLDMAN SACHS GROUP INC
$36.78M-1.8%
UBS Group AG
$36.52M-30.5%
JPMORGAN CHASE & CO
$36.39M+88.4%
JANE STREET GROUP, LLC
$35.09M+20.1%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$31.85M+15.7%
RAYMOND JAMES FINANCIAL INC
$31.00M-61.7%
VANGUARD FIDUCIARY TRUST CO
$28.56M+3.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$28.50M-0.8%
Pictet Asset Management Holding SA
$26.64M-1.9%
Vestal Point Capital, LP
$26.53M-25.6%
NORTHERN TRUST CORP
$24.45M+9.3%
Eversept Partners, LP
$23.52M+152.2%
See all 438 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/VKTX

Earnings Per Share

13fpro.ai/company/VKTX

Loading ratio trend…

VKTX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Viking Therapeutics, Inc. (VKTX): stock profile, AI score and financials

Viking Therapeutics, Inc. (VKTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. VKTX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of VKTX by reported 13-F value include FMR, BlackRock, STATE STREET, based on the most recent SEC filings. VKTX trades on the Nasdaq exchange and files with the SEC under CIK 1607678. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VKTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Viking Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1607678 →